These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22580607)

  • 1. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin.
    Ye Y; Tian H; Lange AR; Yearsley K; Robertson FM; Barsky SH
    Oncogene; 2013 Mar; 32(13):1702-13. PubMed ID: 22580607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7.
    Ye Y; Gao JX; Tian H; Yearsley K; Lange AR; Robertson FM; Barsky SH
    Mol Cancer Res; 2012 Jun; 10(6):713-26. PubMed ID: 22638108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking.
    Ye Y; Tellez JD; Durazo M; Belcher M; Yearsley K; Barsky SH
    Anticancer Res; 2010 Oct; 30(10):3903-10. PubMed ID: 21036701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geometric tumor embolic budding characterizes inflammatory breast cancer.
    Modi AP; Nguyen JPT; Wang J; Ahn JS; Libling WA; Klein JM; Mazumder P; Barsky SH
    Breast Cancer Res Treat; 2023 Feb; 197(3):461-478. PubMed ID: 36473978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
    Tomlinson JS; Alpaugh ML; Barsky SH
    Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.
    Alpaugh ML; Tomlinson JS; Kasraeian S; Barsky SH
    Oncogene; 2002 May; 21(22):3631-43. PubMed ID: 12032865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.
    Alpaugh ML; Tomlinson JS; Ye Y; Barsky SH
    Am J Pathol; 2002 Aug; 161(2):619-28. PubMed ID: 12163386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of tumor dormancy by the lymphovascular embolus.
    Ye Y; Wang J; Izban MG; Ballard BR; Barsky SH
    Oncotarget; 2024 Oct; 15():726-740. PubMed ID: 39392391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated E-cadherin potentiates cell death in prostate epithelial cells.
    Rios-Doria J; Day ML
    Prostate; 2005 May; 63(3):259-68. PubMed ID: 15538719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis.
    Morales J; Alpaugh ML
    BMC Cancer; 2009 Dec; 9():462. PubMed ID: 20028562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo.
    Alpaugh ML; Barsky SH
    Hum Gene Ther; 2002 Jul; 13(10):1245-58. PubMed ID: 12133277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.
    Rios-Doria J; Day KC; Kuefer R; Rashid MG; Chinnaiyan AM; Rubin MA; Day ML
    J Biol Chem; 2003 Jan; 278(2):1372-9. PubMed ID: 12393869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction.
    Xiao Y; Ye Y; Zou X; Jones S; Yearsley K; Shetuni B; Tellez J; Barsky SH
    Oncogene; 2011 Jan; 30(3):287-300. PubMed ID: 20838375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.
    Trillsch F; Kuerti S; Eulenburg C; Burandt E; Woelber L; Prieske K; Eylmann K; Oliveira-Ferrer L; Milde-Langosch K; Mahner S
    Br J Cancer; 2016 Jan; 114(2):213-20. PubMed ID: 26757261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
    J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
    Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
    Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
    Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
    Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.
    Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH
    Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
    Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.